DIADEMA PARTNERS LP

Position in JNJ — Johnson & Johnson

CIK 2026172 MORRISTOWN, NJ

Back to JNJ Full portfolio

Position in JNJ

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$5,587,340

-$7,556,443 QoQ

Shares Held

22,000

-59.1% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

2.11%

of 13F equity value

Holder Rank

#1,544

of 4,676 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in JNJ Over Time

Shares Held

Position Value (USD)

Derivatives in JNJ

reported options exposure · as of Dec 31, 2025

CallValue

$10,347,500

CallShares

50,000

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

DIADEMA PARTNERS LP holds $10,595,985 across 3 Drug Manufacturers - General names. JNJ ranks #1 (52.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson This page	22,000	$5,587,340
2	NVO	Novo Nordisk A S	100,000	$4,794,000
3	AMGN	Amgen Inc	102,701	$214,645

All Filings in JNJ

Export CSV

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,587,340	22,000	-59.1%	Shares	Sole	2026-08-14
2026-03-31	$13,143,783	53,771	-19.1%	Shares	Sole	2026-05-15
2025-12-31	$13,750,585	66,444	—	Shares	Sole	2026-02-17
2025-12-31	$10,347,500	50,000	—	Call	Sole	2026-02-17
No filing history on record for this holder in this stock.